Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
CancerChildhood CancerChemotherapy-induced Peripheral Neuropathy
Interventions
DEVICE

Anodyne Therapy System

Survivors will be provided the Anodyne Therapy System Model 120 to use as part of a 6-week at-home light therapy intervention. Participants will be instructed on where apply the device based on location of their symptoms, and will be instructed to use the device for 15 minutes per day, 3 days per week. Proper use of the device will be demonstrated in clinic by a trained physical therapist or study team member.

Trial Locations (2)

06520

RECRUITING

Yale New Haven Health Smilow York Street Hospital, New Haven

06611

RECRUITING

Yale New Haven Health Park Avenue Medical Center, Trumbull

All Listed Sponsors
collaborator

Rally Foundation for Childhood Cancer Research

OTHER

lead

Yale University

OTHER

NCT07019259 - Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors | Biotech Hunter | Biotech Hunter